Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis.
Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis.
复制标题
DOI:
10.1186/s12933-023-01927-z
复制
发表时间:
2023-08-10
影响因子:
9.3
通讯作者:
Xu H
中科院分区:
文献类型:
--
作者:
Guan B;Wang A;Xu H
Emerging evidence suggests that remnant cholesterol (RC) is strongly associated with an increased incidence of cardiometabolic diseases (CMD). However, the causality have not been confirmed. We aimed to evaluate the causal associations of RC with CMD and the relative risk factors using two-sample Mendelian randomization (MR) methods. Summary-level statistics of RC, CMD, and cardiometabolic risk factors were obtained from the published data from individuals with a predominantly European ancestry mainly from the UK Biobank and the FinnGen biobank. Univariable and multivariable MR analyses were used to evaluate the causal relationships between RC and CMD. A bidirectional MR analysis was performed to estimate the causality between RC and cardiometabolic risk factors. The main MR method was conducted using the inverse-variance weighted method. Univariable MR analyses showed that genetically predicted RC was causally associated with higher risk of ischemic heart disease, myocardial infarction, atrial fibrillation and flutter, peripheral artery disease, and non-rheumatic valve diseases (all P < 0.05). Multivariable MR analyses provided compelling evidence of the harmful effects of RC on the risk of ischemic heart disease (P < 0.05). Bidirectional MR analysis demonstrated that RC was bidirectionally causally linked to total cholesterol, triglycerides, low-density lipoprotein cholesterol, hypercholesterolemia (all P < 0.05). However, no genetic association was found between RC and metabolic disorders or the other cardiometabolic risk factors. This MR study demonstrates that genetically driven RC increases the risk of several CMD and cardiometabolic risk factors, suggesting that targeted RC-lowering therapies may be effective for the primary prevention of CMD. The online version contains supplementary material available at 10.1186/s12933-023-01927-z.
登录
查看更多内容
影响因子:
5.3
作者:
de Vries, Jeroen K.;Balder, Jan W.;Smit, Andries J.
通讯作者:
Smit, Andries J.
影响因子:
16.2
作者:
Mordi IR;Lumbers RT;Palmer CNA;Pearson ER;Sattar N;Holmes MV;Lang CC;HERMES Consortium
通讯作者:
HERMES Consortium
影响因子:
37.8
作者:
Dale CE;Fatemifar G;Palmer TM;White J;Prieto-Merino D;Zabaneh D;Engmann JEL;Shah T;Wong A;Warren HR;McLachlan S;Trompet S;Moldovan M;Morris RW;Sofat R;Kumari M;Hyppönen E;Jefferis BJ;Gaunt TR;Ben-Shlomo Y;Zhou A;Gentry-Maharaj A;Ryan A;UCLEB Consortium; METASTROKE Consortium;Mutsert R;Noordam R;Caulfield MJ;Jukema JW;Worrall BB;Munroe PB;Menon U;Power C;Kuh D;Lawlor DA;Humphries SE;Mook-Kanamori DO;Sattar N;Kivimaki M;Price JF;Davey Smith G;Dudbridge F;Hingorani AD;Holmes MV;Casas JP
通讯作者:
Casas JP
DOI:
10.1161/atvbaha.116.308834
发表时间:
2017-05-01
影响因子:
8.7
作者:
Moens, Sophie J. Bernelot;Verweij, Simone L.;Kroon, Jeffrey
通讯作者:
Kroon, Jeffrey
影响因子:
16.2
作者:
Satoh, A;Adachi, H;Imaizumi, T
通讯作者:
Imaizumi, T